DIURNAL MONITORING OF BLOOD-PRESSURE AND THE RENIN-ANGIOTENSIN SYSTEM IN HYPERTENSIVE PATIENTS ON LONG-TERM ANGIOTENSIN CONVERTING ENZYME-INHIBITION

被引:9
作者
GADSBOLL, N
NIELSEN, MD
GIESE, J
LETH, A
LONBORGJENSEN, H
机构
[1] UNIV COPENHAGEN,GLOSTRUP HOSP,DEPT CLIN PHYSIOL & NUCL MED,DK-1168 COPENHAGEN,DENMARK
[2] UNIV COPENHAGEN,GLOSTRUP HOSP,DEPT INTERNAL MED C,DK-1168 COPENHAGEN,DENMARK
关键词
Angiotensin converting enzyme inhibition; Blood pressure; Diurnal variation; Enalapril;
D O I
10.1097/00004872-199008000-00007
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The temporal blood pressure course and the diurnal profile of the renin-angiotensin system were examined in 13 patients with essential hypertension receiving hydrochlorothiazide and enalapril once daily. Blood samples were taken and blood pressure was measured before the habitual morning dose of hydrochlorothiazide and enalapril (at 8.00 a.m.) and at seven time points over the next 24 h. During the period of maximal effect of enalapril (from 11.00 a.m. to 2.00 p.m.), the increase in plasma renin concentration ranged from no change to an 800% increase. A negative correlation was observed between an increase in plasma renin and a decrease in immunoreactive plasma angiotensin II concentration (Spearman rank-order correlation coefficient = 0.83). Notably, the greatest changes in plasma renin and angiotensin II concentrations after enalapril were seen in those patients whose blood pressure fell most during the day. We conclude that hypertensive patients on long-term therapy with enalapril once daily vary widely in their between-dose biochemical response to the drug, and that there is a significant association between the responsiveness of the plasma renin-angiotensin system and the effect on 24 h blood pressure. © Current Science Ltd.
引用
收藏
页码:733 / 740
页数:8
相关论文
共 19 条
  • [1] THE PHARMACODYNAMICS AND DOSE-RESPONSE RELATIONSHIPS OF THE ANGIOTENSIN CONVERTING-ENZYME-INHIBITOR, CILAZAPRIL, IN ESSENTIAL-HYPERTENSION
    AJAYI, AA
    ELLIOTT, HL
    REID, JL
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 22 (02) : 167 - 175
  • [2] ANTIHYPERTENSIVE THERAPY WITH MK-421 - ANGIOTENSIN-II-RENIN RELATIONSHIPS TO EVALUATE EFFICACY OF CONVERTING ENZYME BLOCKADE
    BIOLLAZ, J
    BRUNNER, HR
    GAVRAS, I
    WAEBER, B
    GAVRAS, H
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1982, 4 (06) : 966 - 972
  • [3] BRUNNER HR, 1986, J HYPERTENS, V4, pS89
  • [4] GADSBOLL N, 1986, J HYPERTENS, V4, pS474
  • [5] GADSBOLL N, 1987, Journal of Cardiovascular Pharmacology, V10, pS163
  • [6] GAVRAS H, 1981, LANCET, V2, P543
  • [7] Giese J, 1983, J Hypertens Suppl, V1, P31
  • [8] PLASMA RENIN CONCENTRATION MEASURED BY USE OF RADIOIMMUNOASSAY FOR ANGIOTENSIN-I
    GIESE, J
    JORGENSEN, M
    NIELSEN, MD
    LUND, JO
    MUNCK, O
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1970, 26 (04) : 355 - +
  • [9] GIESE J, 1981, HETEROGENEITY RENIN, P205
  • [10] LIVER ANGIOTENSINOGEN SYNTHESIS AND RELEASE DURING CAPTOPRIL TREATMENT IN SODIUM-DEPLETED RATS
    JARAMILLO, HN
    SAMBHI, MP
    BOUHNIK, J
    CORVOL, P
    MENARD, J
    [J]. ENDOCRINOLOGY, 1987, 120 (04) : 1384 - 1390